{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:36:52Z","timestamp":1792431412548,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.ejphar.2020.173747","type":"journal-article","created":{"date-parts":[[2020,11,21]],"date-time":"2020-11-21T10:54:19Z","timestamp":1605956059000},"page":"173747","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Anti-cancer activity of two novel heterocyclic compounds through modulation of VEGFR and miR-122 in mice bearing Ehrlich ascites carcinoma"],"prefix":"10.1016","volume":"892","author":[{"given":"Reem M.","family":"Hazem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anhar A.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagat","family":"Ghareb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman T.","family":"Mehanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha M.","family":"Mesbah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina M.","family":"Abo-Elmatty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0910-2893","authenticated-orcid":false,"given":"Mohamed Saleh","family":"Elgawish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2020.173747_bib1","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1007\/s12010-016-2256-8","article-title":"WNT1 gene from WNT signaling pathway is a direct target of miR-122 in hepatocellular carcinoma","volume":"181","author":"Ahsani","year":"2017","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.ejphar.2020.173747_bib2","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s12072-016-9729-2","article-title":"Impact of circulating miR-122 for histological features and hepatocellular carcinoma of nonalcoholic fatty liver disease in Japan","volume":"10","author":"Akuta","year":"2016","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.ejphar.2020.173747_bib3","first-page":"289","article-title":"Neoangiogenesis in cervical cancer: focus on CD34 assessment. Rom","volume":"51","author":"Ancuta","year":"2010","journal-title":"J. Morphol. Embryol."},{"key":"10.1016\/j.ejphar.2020.173747_bib4","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejphar.2020.173747_bib5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/jcp.22126","article-title":"miR-20b modulates VEGF expression by targeting HIF-1 Alpha and STAT3 in MCF-7 breast cancer cells","volume":"224","author":"Cascio","year":"2010","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejphar.2020.173747_bib6","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3892\/ol.2015.3348","article-title":"Expression of cluster of differentiation 34 and vascular endothelial growth factor in breast cancer, and their prognostic significance","volume":"10","author":"Chen","year":"2015","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ejphar.2020.173747_bib7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nrd773","article-title":"Protein kinases-the major drug targets of the twenty-first century","volume":"1","author":"Cohen","year":"2001","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2020.173747_bib8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1634\/theoncologist.12-3-253","article-title":"Achievements in systemic therapies in the pregenomic era in metastatic breast cancer","volume":"12","author":"Colozza","year":"2007","journal-title":"Oncol."},{"key":"10.1016\/j.ejphar.2020.173747_bib9","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1038\/onc.2009.211","article-title":"Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties","volume":"28","author":"Coulouarn","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2020.173747_bib10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1208\/s12248-009-9159-3","article-title":"Small molecule modifiers of the microRNA and RNA interference pathway","volume":"12","author":"Deiters","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.ejphar.2020.173747_bib11","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.ctrv.2011.11.005","article-title":"Molecular biology in breast cancer: intrinsic subtypes and signaling pathways","volume":"38","author":"Eroles","year":"2012","journal-title":"Canc. Treat Rev."},{"key":"10.1016\/j.ejphar.2020.173747_bib12","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2020.173747_bib13","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/bcr1796","article-title":"Breast tumour angiogenesis","volume":"9","author":"Fox","year":"2007","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.ejphar.2020.173747_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.440","article-title":"Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers","volume":"8","author":"Hamam","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2020.173747_bib15","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.cellsig.2007.05.013","article-title":"Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition","volume":"19","author":"Holmes","year":"2007","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejphar.2020.173747_bib16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.gene.2017.05.014","article-title":"Differences in the MicroRNA profiles of subcutaneous adipose-derived stem cells and omental adipose-derived stem cells","volume":"625","author":"Hu","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.ejphar.2020.173747_bib17","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1016\/j.ejca.2014.06.005","article-title":"microRNA-128 plays a critical role in human non-small cell lung cancer tumorigenesis, angiogenesis and lymph angiogenesis by directly targeting vascular endothelial growth factor-C","volume":"50","author":"Hu","year":"2014","journal-title":"Eur. J. Canc."},{"key":"10.1016\/j.ejphar.2020.173747_bib18","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1371\/journal.pone.0000116","article-title":"MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia","volume":"1","author":"Hua","year":"2006","journal-title":"PloS One"},{"key":"10.1016\/j.ejphar.2020.173747_bib19","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1182\/blood-2012-05-433045","article-title":"Transcriptional repression of VEGF by ZNF24: mechanistic studies and vascular consequences in vivo","volume":"121","author":"Jia","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2020.173747_bib20","doi-asserted-by":"crossref","first-page":"2","DOI":"10.31768\/2312-8852.2018.40(1):2-9","article-title":"Role of components of microRNA machinery in carcinogenesis","volume":"40","author":"Kian","year":"2018","journal-title":"Exp. Oncol."},{"key":"10.1016\/j.ejphar.2020.173747_bib21","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10555-018-9734-0","article-title":"Roles of prostaglandins in tumor associated lymphangiogenesis with special reference to breast cancer","volume":"37","author":"Lala","year":"2018","journal-title":"Canc. Metastasis Rev."},{"key":"10.1016\/j.ejphar.2020.173747_bib22","first-page":"543","article-title":"Determination of sensitivity of individual biopsy specimens to potential inhibitory agents: evaluation of some explant culture methods as assay systems","volume":"50","author":"Lazarus","year":"1966","journal-title":"Cancer Chemother. Rep."},{"key":"10.1016\/j.ejphar.2020.173747_bib23","doi-asserted-by":"crossref","first-page":"115787","DOI":"10.18632\/oncotarget.23115","article-title":"MicroRNAs in cancer metastasis and angiogenesis","volume":"8","author":"Lou","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2020.173747_bib24","doi-asserted-by":"crossref","first-page":"554","DOI":"10.4161\/cbt.9.7.11267","article-title":"Expression of miR-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cancer cells","volume":"9","author":"Ma","year":"2010","journal-title":"Canc. Biol. Ther."},{"key":"10.1016\/j.ejphar.2020.173747_bib25","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10549-012-1957-0","article-title":"Prognostic impact of placenta growth factor and vascular endothelial growth factor A in patients with breast cancer","volume":"133","author":"Maae","year":"2012","journal-title":"Breast Canc. Res. Treat."},{"key":"10.1016\/j.ejphar.2020.173747_bib26","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ijc.30433","article-title":"Plasma miR-122 and miR-200 family are prognostic markers in colorectal cancer","volume":"140","author":"Maierthaler","year":"2017","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.ejphar.2020.173747_bib27","article-title":"Opposing roles for CD34 in B16 melanoma tumor growth alter early stage vasculature and late stage immune cell infiltration","volume":"64","author":"Maltby","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.ejphar.2020.173747_bib28","doi-asserted-by":"crossref","first-page":"10797","DOI":"10.1021\/jm301085w","article-title":"Vascular endothelial growth factor (VEGF) receptors: drugs and new inhibitors","volume":"55","author":"Musumeci","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2020.173747_bib29","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/10739680902941737","article-title":"CD34 is a key regulator of hematopoietic stem cell trafficking to bone marrow and mast cell progenitor trafficking in the periphery","volume":"16","author":"Nielsen","year":"2009","journal-title":"Microcirculation"},{"key":"10.1016\/j.ejphar.2020.173747_bib30","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrm1911","article-title":"VEGF receptor signaling - in control of vascular function","volume":"7","author":"Olsson","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2020.173747_bib31","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bcmd.2007.04.001","article-title":"Understanding the biology of angiogenesis: review of the most important molecular mechanisms","volume":"39","author":"Otrock","year":"2007","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ejphar.2020.173747_bib32","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/1878-0261.12483","article-title":"New insights into radioresistance in breast cancer identify a dual function of miR-122 as a tumor suppressor and oncomiR","volume":"13","author":"Perez-A\u00f1orve","year":"2019","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.ejphar.2020.173747_bib33","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1080\/13543776.2017.1344215","article-title":"VEGFR-2 inhibitors and the therapeutic applications thereof: a patent review (2012-2016)","volume":"27","author":"Peng","year":"2017","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejphar.2020.173747_bib34","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3126\/jpn.v4i7.10315","article-title":"A study on microvascular density in breast carcinoma","volume":"4","author":"Pyakurel","year":"2014","journal-title":"J. Pathol. Nepal"},{"key":"10.1016\/j.ejphar.2020.173747_bib35","first-page":"3175","article-title":"miR-122 inhibits metastasis and epithelial-mesenchymal transition of non-small-cell lung cancer cells","volume":"8","author":"Qin","year":"2015","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.ejphar.2020.173747_bib36","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.pathophys.2009.11.003","article-title":"Lymphangiogenesis and lymphatic metastasis in breast cancer","volume":"17","author":"Ran","year":"2010","journal-title":"Pathophysiology"},{"key":"10.1016\/j.ejphar.2020.173747_bib37","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nature04874","article-title":"Mechanisms of drug inhibition of signalling molecules","volume":"441","author":"Sebolt-Leopold","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2020.173747_bib38","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1177\/1947601911423031","article-title":"Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti- and pro-angiogenic therapies","volume":"2","author":"Shibuya","year":"2011","journal-title":"Genes Cancer"},{"key":"10.1016\/j.ejphar.2020.173747_bib39","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1369\/0022155412467635","article-title":"Endothelial tip cells in ocular angiogenesis: potential target for anti-angiogenesis therapy","volume":"61","author":"Siemerink","year":"2013","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.ejphar.2020.173747_bib40","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrgastro.2012.210","article-title":"The role of microRNAs in cancers of the upper gastrointestinal tract","volume":"10","author":"Song","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2020.173747_bib41","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1158\/0008-5472.CAN-16-0359","article-title":"Oncomir or tumor suppressor? The duplicity of microRNAs in cancer","volume":"76","author":"Svoronos","year":"2016","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.ejphar.2020.173747_bib42","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/CIRCRESAHA.108.191270","article-title":"MicroRNAs as novel regulators of angiogenesis","volume":"104","author":"Su\u00e1rez","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2020.173747_bib43","first-page":"1127","article-title":"Occurrence and outcome of de novo metastatic breast cancer by subtype in a large, diverse population","volume":"27","author":"Tao","year":"2016","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ejphar.2020.173747_bib44","doi-asserted-by":"crossref","first-page":"21221","DOI":"10.1038\/srep21221","article-title":"Overexpression of miRNA-497 inhibits tumor angiogenesis by targeting VEGFR2","volume":"6","author":"Tu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2020.173747_bib45","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1158\/0008-5472.CAN-03-1957","article-title":"Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis","volume":"64","author":"Uzzan","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejphar.2020.173747_bib46","doi-asserted-by":"crossref","first-page":"112008","DOI":"10.1016\/j.ejmech.2019.112008","article-title":"A review of currently identified small molecule modulators of microRNA function","volume":"188","author":"Van Meter","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2020.173747_bib47","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1021\/cb400668h","article-title":"Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules","volume":"9","author":"Vo","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejphar.2020.173747_bib48","article-title":"MiR-122 inhibits cell proliferation and tumorigenesis of breast cancer by targeting IGF1R","volume":"7","author":"Wang","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.ejphar.2020.173747_bib49","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12943-018-0766-4","article-title":"New insights into the regulatory role of microRNA in tumor angiogenesis and clinical implications","volume":"17","author":"Wang","year":"2018","journal-title":"Mol. Canc."},{"key":"10.1016\/j.ejphar.2020.173747_bib50","first-page":"3056","article-title":"MiR-122 targets VEGFC in bladder cancer to inhibit tumor growth and angiogenesis","volume":"8","author":"Wang","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.ejphar.2020.173747_bib51","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.aohep.2019.07.005","article-title":"Over-expression of MiR-122 promotes apoptosis of hepatocellular carcinoma via targeting TLR4","volume":"18","author":"Wei","year":"2019","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.ejphar.2020.173747_bib52","first-page":"724","article-title":"Squalamine treatment of human tumors in nu\/nu mice enhances platinum-based chemotherapies","volume":"7","author":"Williams","year":"2001","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.ejphar.2020.173747_bib53","doi-asserted-by":"crossref","first-page":"7976","DOI":"10.1021\/ja910275u","article-title":"Small molecule modifiers of MicroRNA miR-122 function for the treatment of hepatitis C Virus infection and hepatocellular carcinoma","volume":"132","author":"Young","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejphar.2020.173747_bib54","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1746-1596-8-170","article-title":"The relationship between lymphatic vascular density and vascular endothelial growth factor A (VEGF-A) expression with clinical-pathological features and survival in pancreatic adenocarcinomas","volume":"8","author":"Zorgetto","year":"2013","journal-title":"Diagn. Pathol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920308396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920308396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:48:38Z","timestamp":1757976518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299920308396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":54,"alternative-id":["S0014299920308396"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173747","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-cancer activity of two novel heterocyclic compounds through modulation of VEGFR and miR-122 in mice bearing Ehrlich ascites carcinoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173747","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173747"}}